Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 226,200 shares, a decrease of 41.9% from the May 31st total of 389,400 shares. Based on an average daily trading volume, of 192,500 shares, the days-to-cover ratio is presently 1.2 days.
Coloplast A/S Price Performance
OTCMKTS:CLPBY traded down $0.08 during trading hours on Friday, hitting $12.08. The company’s stock had a trading volume of 57,026 shares, compared to its average volume of 116,107. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.39 and a current ratio of 0.60. Coloplast A/S has a 52-week low of $9.90 and a 52-week high of $14.34. The stock has a fifty day moving average of $12.31 and a 200-day moving average of $12.45.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.08. Coloplast A/S had a net margin of 19.45% and a return on equity of 36.74%. The company had revenue of $959.05 million during the quarter. Equities research analysts expect that Coloplast A/S will post 0.34 EPS for the current fiscal year.
Coloplast A/S Cuts Dividend
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Featured Stories
- Five stocks we like better than Coloplast A/S
- Dividend Payout Ratio Calculator
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.